Incipiam Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 44074214
Teknikerbyen 5, Søllerød 2830 Virum
caspertind@gmail.com
tel: 45484449
Income statement (kDKK)
2023 | 2024 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | -13.47 | -97.76 |
Wages and salaries | -30.27 | |
EBIT | -13.47 | - 128.03 |
Pre-tax profit | -13.47 | - 128.03 |
Net earnings | -13.47 | - 128.03 |
Assets (kDKK)
2023 | 2024 | |
---|---|---|
Intangible assets total | ||
Tangible assets total | ||
Investments total | ||
Long term receivables total | ||
Inventories total | ||
Current other receivables | 26.53 | 23.76 |
Short term receivables total | 26.53 | 23.76 |
Cash and bank deposits | 4 448.66 | |
Cash and cash equivalents | 4 448.66 | |
Balance sheet total (assets) | 26.53 | 4 472.42 |
Equity and liabilities (kDKK)
2023 | 2024 | |
---|---|---|
Share capital | 40.00 | 40.00 |
Retained earnings | -13.47 | |
Profit of the financial year | -13.47 | - 128.03 |
Shareholders equity total | 26.53 | - 101.50 |
Non-current liabilities total | ||
Other non-interest bearing current liabilities | 4 573.91 | |
Current liabilities total | 4 573.91 | |
Balance sheet total (liabilities) | 26.53 | 4 472.42 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.